ENSG earnings analysis
What we found in ENSG's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Ensign delivered strong Q2 growth, with revenue of $1.440 billion (+17.3% year over year) and diluted EPS of $1.68 (+16.7%), supported by acquisitions, higher occupancy, and patient acuity. Operating margin held at 8.5% year over year but declined from 9.0% in Q1, reflecting higher G&A and depreciation associated with expansion and system implementation. Operating cash flow remained robust at $272.1 million for the first six months, though acquisitions and buybacks reduced cash to $262.3 million. The central risks are Medicaid-policy exposure, the DOJ CID and active reimbursement reviews, and elevated regulatory scrutiny of SNFs.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Double-digit revenue growth and EPS advance
- Q2 revenue rose 17.3% year over year to $1.440 billion and increased 3.6% sequentially from $1.390 billion in Q1 2026. Diluted GAAP EPS increased 16.7% year over year to $1.68 and edged up from $1.67 in Q1.
- Margins stable year over year
- Operating margin was 8.5%, unchanged from Q2 2025's 8.5%, while sequentially it declined 50 basis points from 9.0% in Q1 2026. Skilled-services cost of services improved 60 basis points year over year to 78.9% of revenue, aided by lower agency expense and ancillary efficiencies.
- Broad skilled-services growth
- Skilled-services revenue increased $206.3 million, or 17.6%, to $1.380 billion. Same-facility revenue grew 6.6% to $988.3 million, transitioning-facility revenue grew 6.1% to $197.4 million, and recently acquired facilities added $133.5 million of growth.
- REIT segment scales rapidly
- Standard Bearer rental revenue grew 40.2% to $44.1 million and FFO rose 34.6% to $24.7 million, supported by 37 real-estate purchases. Segment income increased 32.3% to $12.1 million despite $5.1 million more interest expense.
- Occupancy and acuity improved
- Occupancy rose to 82.9% from 81.3% a year earlier, while skilled mix by revenue increased to 50.0% from 49.2%. Same-facility occupancy reached 84.1%, up from 81.9%, supporting management's demand and acuity narrative.
- Strong operating cash generation funds growth
- Six-month operating cash flow increased $44.2 million year over year to $272.1 million; less $88.3 million of property capex, implied free cash flow was $183.8 million. The company also deployed $376.0 million for acquisitions and repurchased $40.0 million of stock, with $60.0 million remaining authorized.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- High Medicaid exposure amid funding reform
- Medicaid represented 45.2% of Q2 revenue, leaving reimbursement exposed to Medicaid funding reform. The OBBB provides that grandfathered state-directed payments decline 10% annually beginning January 1, 2028, while the company says state-budget pressure could result in lower SNF reimbursement rates.
- DOJ investigation and active claim reviews
- The DOJ's January 2024 Civil Investigative Demand covers Medicare and Texas Medicaid claims from January 1, 2016 to the present. Separately, 18 independent subsidiaries had multi-claim reviews scheduled or in process as of June 30, 2026, creating recoupment, fine, and reimbursement-risk exposure.
- Acquisition spending reduced cash balance
- Cash and cash equivalents fell $241.6 million in the first six months to $262.3 million as investing outflows reached $478.9 million, including $376.0 million for acquisitions. While there were no credit-facility borrowings, the $600.0 million facility matures April 8, 2027 and fixed-rate mortgage/note debt totaled $142.3 million.
- Litigation and labor-cost exposure
- A California wage-and-hour class/representative-action settlement for a six-year period ending December 2025 totals $12.0 million, pending court approval. A July 16, 2026 derivative complaint also seeks unspecified damages and governance reforms, with no amount accrued.
- Rate and quality-reporting uncertainty
- CMS proposed a 2.4% net FY 2027 SNF payment-rate increase, composed of a 3.2% market-basket update less a 0.8% productivity adjustment, but the proposal remains subject to finalization. The company also notes that facilities failing SNF quality-reporting requirements can face a 2.0% payment reduction.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $1.68
- Operating margin
- 8.5%
- Segment
- Skilled services revenue: $1.380 billion, up 17.6% year over year
- Segment
- Standard Bearer rental revenue: $44.1 million, up 40.2% year over year
- Segment
- All Other revenue: $64.3 million, up 12.1% year over year
What they said about what is next.
The 10-Q contains no explicit updated annual revenue or EPS guidance. Management states that $262.3 million of cash, $268.6 million of investments, projected operating cash flow and available financing are expected to support normal operations for the foreseeable future; it also cites approximately $175.0 million of 2026 renovation-project spending budgeted.
The filing reads better than the one before it.
What came before.
- 10-Q · April 30, 2026
- The Ensign Group's Q1 2026 earnings report indicates a strong surge in revenue and earnings per share compared to both the prior quarter and the same period last year, driven by improved occupancy rates and successful…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing ENSG makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever